DENTSPLY SIRONA Inc. (NASDAQ:XRAY) saw a downside of -4.06% to close Tuesday at $35.89 after subtracting -$1.52 on the day. The 5-day average trading volume is 1,839,960 shares of the company’s common stock. It has gained $37.81 in the past week and touched a new high 2 times within the past 5 days. An average of 1,974,015 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,160,602.
XRAY’s 1-month performance is 14.55% or $4.06 on its low of $30.84 reached on 12/29/22. The company’s shares have touched a 52-week low of $26.48 and high of $58.70, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, XRAY has achieved 12.72% or $4.05 and has reached a new high 8 times. However, the current price is down -38.86% from the 52-week high price.
XRAY stock investors last saw insider trading activity on Nov 15.BRANDT ERIC (Director) most recently sold 6,900 shares at $39.71 per share on May 03. This transaction cost the insider $273,999.
XRAY stock has a beta of 0.93. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.91 while the price-to-book (PB) in the most recent quarter is 2.14, with the price to cash flow ratio at 16.90.
DENTSPLY SIRONA Inc.’s quick ratio for the period ended March 30 was 1.00, with the current ratio over the same period at 1.50. As well, the company’s long term debt to equity for the quarter ending March 30 was 0.48, while the total debt to equity was 0.55.. In terms of profitability, the gross margin trailing 12 months is 54.60%. The firm’s gross profit as reported stood at $2.35 billion against revenue of $4.23 billion.
For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 107.8% to -$1.08 billion, while revenue of $73.0 million was 106.78% off the previous quarter. Analysts expected XRAY to announce $0.56 per share in earnings in its latest quarter, but it posted $0.52, representing a -7.10% surprise. EBITDA for the quarter stood at more than $51.0 million. XRAY stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 3.91 billion, with total debt at $2.38 billion. Shareholders hold equity totaling $214.91 million.
Let’s look briefly at DENTSPLY SIRONA Inc. (XRAY) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 57.94% to suggest the stock is trending Neutral, with historical volatility in this time period at 37.03%.
The stock’s 5-day moving average is $36.76, reflecting a -2.53% or -$0.93 change from its current price. XRAY is currently trading +14.01% above its 20-day SMA, +8.96% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +24.88% and SMA200 by-25.65%.
Stochastic %K and %D was 81.80% and 85.74% and the average true range (ATR) pointed at 1.08. The RSI (14) points at 60.83%, while the 14-day stochastic is at 63.77% with the period’s ATR at 1.09. The stock’s 9-day MACD Oscillator is pointing at 0.28 and 1.41 on the 14-day charts.
In the most recent analyst report for DENTSPLY SIRONA Inc. (NASDAQ: XRAY), William Blair upgraded it to a Mkt perform rating. They previously had an Underperform rating on the stock. Analysts offering their rating for XRAY stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate XRAY as a “sell,”, while 8 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 5 have offered a “buy” rating.
What is XRAY’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $29.00 and a high of $40.00, with their median price target at $34.00. Looking at these predictions, the average price target given by analysts is for DENTSPLY SIRONA Inc. (XRAY) stock is $34.91.